Phase III Trial of High Dose vs. Standard Dose Vit D2 With Docetaxel in Met Breast ca
Status:
Unknown status
Trial end date:
2012-07-01
Target enrollment:
Participant gender:
Summary
Randomized phase III trial to determine the effectiveness of High dose versus Standard dose
of Vitamin D2 (Ergocalciferol) given with Docetaxel in patients with metastatic breast cancer